retatrutide clinical trial information A new from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes Retatrutide Contraindications: Risks and Considerations

Each supplement is slightly different, but these are a few ingredients that have come up: L-taurine (an amino acid) Prebiotics (fibre that feed good bacteria in your gut) Boron (a trace element) Berberine (a plant-based substance) Eriomin (lemon extract) Supresa (saffron extract) Morosil (blood orange extract) Green tea leaf extract (concentrated green tea) These can all impact the body, yes, but its a stretch to suggest that these would have the same effect as GLP-1 receptor agonist medications, says Dr Mir Ali, a bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center

Retatrutide vs Tirzepatide (Mounjaro): 28.7% vs 22.5% (2026 Data) Phase 3 trial comparison: Retatrutide 28.7% weight loss vs Tirzepatide 22.5%

It does not activate GIPR

Participants were randomized in a 2:1:1:1:1:2:2 ratio to once-weekly subcutaneous retatrutide at 1 mg, 4 mg, 8 mg, or 12 mg, or placebo, over a 48-week treatment period

practitioners rarely agree on the best dose of any particular peptide, even less so when combining multiple

Sarah Glinski, RD Author Sarah is a registered dietitian and accomplished health and nutrition writer known for her expertise in crafting engaging content